Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer
Top Cited Papers
- 1 August 2005
- journal article
- review article
- Published by Elsevier
- Vol. 1 (2) , 101-109
- https://doi.org/10.1016/j.nano.2005.03.002
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistanceProceedings of the National Academy of Sciences, 2005
- Systems Biology and New Technologies Enable Predictive and Preventative MedicineScience, 2004
- Finishing the euchromatic sequence of the human genomeNature, 2004
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- The promise of cancer vaccinesNature Reviews Cancer, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNature Biotechnology, 2003
- Initial sequencing and analysis of the human genomeNature, 2001